ADIPOQ Kit ELISA

N° du produit ABIN2745426

Ce kit ELISA Colorimetric est destiné à la mesure quantitative de Humain ADIPOQ.

Aperçu rapide pour ADIPOQ Kit ELISA (ABIN2745426)

Antigène: ADIPOQ (Adiponectin (ADIPOQ))

Reactivité: Humain

Méthode de détection: Colorimetric

Type de méthode: Sandwich ELISA

Gamme de detection: 0.5-32 ng/mL

Application: ELISA

Type d'échantillon: Cell Culture Supernatant, Plasma, Serum, Urine

Détail du produit ADIPOQ Kit ELISA

Seuil minimal de détection: 0.5 ng/mL

Fonction: The Adiponectin (human) ELISA Kit is to be used for the in vitro quantitative determination of human Adiponectin in serum, plasma, urine and cell culture supernatant.

Analytical Method: Quantitative

Specificité: Detects human adiponectin.

Réactivité croisée: Humain

Aucune reactivité croisée: Souris, Rat (Rattus)

Réactivité croisée (Details): Does not cross-react with mouse adiponectin, rat adiponectin, human resistin, human RELM-beta or human leptin.

Sensibilité: 100 pg/mL

Attributs du produit: Adiponectin (human) ELISA Kit (Twin Plex)

Information d'application

Plaque: Pre-coated

Restrictions: For Research Use only

Stockage

Stock: 4 °C

Stockage commentaire: Short Term Storage: +4°C
Long Term Storage: +4°C
12 months after the day of manufacturing. See expiry date on ELISA Kit box.

Détail du antigène

Antigène: ADIPOQ (Adiponectin (ADIPOQ))

Autre désignation: Adiponectin

Sujet: Adiponectin [ACRP30, AdipoQ] is a promising biomarker of insulin resistance and type 2 diabetes mellitus (T2DM) but also as a potential target for management of the metabolic syndrome. It is a very robust marker that is not prone to degradation or acute inflammatory challenges, is present in relatively high concentrations in the peripheral circulation, and can be collected by a variety of methods. The benefits of using adiponectin assays in clinical settings include, (a) prediction of risk of diabetes and metabolic status and (b) providing a tool to monitor metabolic improvements. Adiponectin exerts anti-atherogenic and anti-inflammatory properties and may be important as a biomarker for obesity-related cardiovascular disease (CVD). New findings showed urinary adiponectin excretion as an independent new biomarker of microvascular and macrovascular damage in T2DM and suggested it as a very promising tool for early cardiovascular disease risk assessment. Adiponectin serum level was also described as a good biomarker of colorectal adenoma, this being related to the positive correlation between obesity and increased risk of cancer at various sites (colorectal, breast, prostate and endometrium).

UniProt: Q15848